Scarica l'app Stockscreener
1.68
6.21%
0.07
Okyo Pharma Limited Borsa (OKYO) Ultime notizie
OKYO Pharma to Highlight Neuropathic Corneal Pain Program at Piper Sandler Virtual Ophthalmology Symposium - TipRanks
OKYO Pharma (OKYO) to join Piper Sandler 2026 Virtual Ophthalmology Symposium fireside chat - Stock Titan
OKYO Pharma CEO to speak at Piper Sandler virtual eye event July 9 - Stock Titan
OKYO Pharma announces participation in Piper Sandler 2026 Virtual Ophthalmology Symposium - Proactive financial news
Price to book forward of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Price to earnings forward of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Enterprise value to EBITDA forward of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Enterprise value to revenue forward of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Enterprise value to EBIT forward of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Enterprise value to EBIT forward of OKYO Pharma Limited – BOATS:OKYO - TradingView
OKYO Pharma Limited Actuals & Estimates (NASDAQ:OKYO) - TradingView
OKYO Pharma Ltd (OKYO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OKYO Pharma And The Small-Cap Eye Care Story - Kalkine Media
OKYO Pharma Ltd (OKYO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OKYO Pharma Ltd (OKYO) Valuation: PE, PB & Fair Value Analysis - TradingKey
OKYO Pharma Ltd (OKYO) Institutional Confidence - TradingKey
OKYO Pharma Ltd (OKYO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OKYO Pharma Ltd (OKYO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OKYO Pharma Ltd (OKYO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OKYO Pharma Ltd (OKYO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OKYO (NASDAQ: OKYO) CMO Mantelli reports multi-year option holdings in Form 3 - Stock Titan
OKYO Pharma (OKYO) director awarded options on 3,500 common shares - Stock Titan
OKYO Pharma (OKYO) director awarded options for 6,500 shares at $1.85 - Stock Titan
Director at OKYO Pharma (NASDAQ: OKYO) receives stock options on 6,500 shares - Stock Titan
OKYO Pharma (OKYO) CFO receives grant of 40,000 options at $1.85 - Stock Titan
OKYO Pharma (OKYO) director adds 300,000-share grant via Panetta Partners - Stock Titan
OKYO Pharma Slips 1.85% as Shares Test Key Support LevelTrend Following Picks - newsline.com
OKYO Pharma (OKYO) Retreats Toward Support as Biotech Sector Faces HeadwindsInverse ETF Flow - newsline.com
OKYO Pharma (OKYO) director reports detailed stock option grants - Stock Titan
OKYO H2'25 Earnings: EPS estimate is (0.08) USD - TradingView
OKYO Pharma (OKYO) director discloses stock and option holdings - Stock Titan
[Form 3] OKYO Pharma Ltd Initial Statement of Beneficial Ownership - Stock Titan
OKYO Pharma Edges Lower, Holds Steady Near Key Support LevelStop Loss Guidance - newsline.com
OKYO Stock Price, Quote & Chart | OKYO PHARMA LTD (NASDAQ:OKYO) - ChartMill
OKYO Pharma (OKYO) Edges Higher on Modest Gains, Holds Above Key SupportSentiment Divergence - The Legal Advocate
OKYO H2'25 Earnings: revenue estimate is 0 USD - TradingView
OKYO Pharma Shares Edge Higher as Biotech Momentum BuildsMFI Overbought - The Legal Advocate
OKYO Pharma expands scientific advisory board with cornea expertICYMI - Proactive financial news
OKYO Pharma Ltd (OKYO) CFO details equity and option positions - Stock Titan
OKYO Pharma (OKYO) CEO discloses multiple stock option positions - Stock Titan
What Makes OKYO Pharma (OKYO) a New Buy Stock - Yahoo Finance
Okyo Pharma Appoints Marta Sacchetti, MD, Ph.D., to Scientific Advisory Board - VisionMonday.com
OKYO Pharma adds Marta Sacchetti to scientific advisory board By Investing.com - Investing.com India
OKYO Pharma appoints Marta Sacchetti to advisory board By Investing.com - Investing.com South Africa
OKYO Pharma Strengthens Scientific Advisory Board With Marta Sacchetti Appointment - Proactive financial news
OKYO Pharma adds ophthalmology specialist Marta Sacchetti to Scientific Advisory Board - Yahoo! Finance Canada
OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain - TipRanks
OKYO Pharma adds Marta Sacchetti to scientific advisory board - Investing.com
OKYO Pharma appoints Marta Sacchetti to advisory board - Investing.com
OKYO Pharma (OKYO) deepens NCP program with new advisory board expert - Stock Titan
OKYO Pharma Limited Expands Scientific Advisory Board with Appointment of Marta Sacchetti - marketscreener.com
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD - GlobeNewswire
Point72 and Steven A. Cohen report 0% stake in OKYO (NASDAQ: OKYO) - Stock Titan
Woodline Partners reports 7.0% stake in OKYO Pharma (NASDAQ: OKYO) - Stock Titan
1.03%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):